0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Levetiracetam"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Neuroprotection - Methods, Drugs, Markets and Companies - Product Thumbnail Image

Neuroprotection - Methods, Drugs, Markets and Companies

  • Report
  • November 2021
  • 844 Pages
  • Global
From
EUR$5,000USDGBP
Plumb's Veterinary Drug Handbook. Edition No. 10 - Product Thumbnail Image

Plumb's Veterinary Drug Handbook. Edition No. 10

  • Book
  • July 2023
  • 1568 Pages
EUR$131USDGBP
The Treatment of Epilepsy. 3rd Edition - Product Thumbnail Image

The Treatment of Epilepsy. 3rd Edition

  • Book
  • July 2009
  • 1116 Pages
EUR$305USDGBP
Loading Indicator

Levetiracetam is a medication used to treat epilepsy and other seizure disorders. It is a type of anticonvulsant drug, which works by reducing the abnormal electrical activity in the brain that causes seizures. Levetiracetam is used to treat partial onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures. It is also used to treat Lennox-Gastaut syndrome, a rare form of epilepsy. Levetiracetam is part of the Central Nervous System (CNS) drug market, which includes medications used to treat neurological disorders such as epilepsy, Parkinson's disease, and Alzheimer's disease. The CNS drug market is highly competitive, with many different drugs available to treat the same condition. Companies in the Levetiracetam market include UCB, Inc., Sun Pharmaceutical Industries Ltd., Mylan N.V., Dr. Reddy's Laboratories Ltd., and Teva Pharmaceutical Industries Ltd. Show Less Read more